Laurence H. Beck Jr, MD, PhD
Associate Professor
Boston University School of Medicine
Dept of Medicine

MD, Harvard Medical School
PhD, Harvard University

Laurence H. Beck, Jr., MD, PhD, completed his Internal Medicine residency and Nephrology fellowship at Boston Medical Center. He joined the Renal Section in 2006, and continues to conduct basic science research in the laboratory of Dr. David Salant on the pathogenesis of membranous nephropathy. His clinical roles include a weekly clinic and attending time on the consult and dialysis/transplant services. He also has expertise in immune-mediated glomerular disease.

Boston University
Evans Center for Interdisciplinary Biomedical Research

Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Graduate Medical Sciences

2019 American Society of Nephrology: Distinguished Researcher Award

10/17/2019 - 10/16/2022 (PI)
Pfizer, Inc

Redefining Membranous Nephropathy by Autoantibody-specific Subclassification
01/22/2013 - 12/31/2018 (PI)

Redifining Membranous Nephropathy by Autoantibody-specific Subclassification
01/22/2013 - 12/31/2018 (PI)

Investigation of Anti-PLA2R-Associated Membranous Nephropathy at the Molecular Level
09/01/2011 - 06/30/2013 (PI)
The Halpin Foundation

Detection of anti-phospholipase A2 receptor autoantibodies in idiopathic membranous nephropathy
07/01/2009 - 06/30/2013 (PI)
Amer Soc Nephrology

Identification of the endogenous antigen and development of an ELISA for the detection of autoantibo
07/01/2007 - 06/30/2013 (PI)

Identification of the Endogenous Antigen and Development of an ELISA for the Detection of Autoantibo
07/01/2007 - 06/30/2009 (PI)
The Halpin Foundation


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Caza TN, Al-Rabadi LF, Beck LH. How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. Front Immunol. 2021; 12:800242. PMID: 34899763; PMCID: PMC8662735; DOI: 10.3389/fimmu.2021.800242;
  2. Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, Troost JP, Chen J, Fermin D, Yee JL, Sampson MG, Beck LH, Henderson JM, Greka A, Rennke HG, Weins A. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol. 2022 Jan; 33(1):238-252.View Related Profiles. PMID: 34732507
  3. Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, Sethi S, Tong A, Vivarelli M, Wetzels J. Membranous nephropathy. Nat Rev Dis Primers. 2021 09 30; 7(1):69. PMID: 34593809
  4. Bomback AS, Appel GB, Gipson DS, Hladunewich MA, Lafayette R, Nester CM, Parikh SV, Smith RJH, Trachtman H, Heeger PS, Ram S, Rovin BH, Ali S, Arceneaux N, Ashoor I, Bailey-Wickins L, Barratt J, Beck L, Cattran DC, Cravedi P, Erkan E, Fervenza F, Frazer-Abel AA, Fremeaux-Bacchi V, Fuller L, Gbadegesin R, Hogan JJ, Kiryluk K, le Quintrec-Donnette M, Licht C, Mahan JD, Pickering MC, Quigg R, Rheault M, Ronco P, Sarwal MM, Sethna C, Spino C, Stegall M, Vivarelli M, Feldman DL, Thurman JM. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2021 Sep 24. PMID: 34571062
  5. Nasr SH, Leung N, Said SM, Alkhateeb HB, Madden BJ, Charlesworth MC, Beck LH, Larsen CP, Sethi S. Membranous Nephropathy With Extensive Tubular Basement Membrane Deposits Following Allogeneic Hematopoietic Cell Transplant: A Report of 5 Cases. Am J Kidney Dis. 2021 Sep 08. PMID: 34508832
  6. Molina Andújar A, Castrejon de Anta N, Rodriguez-Espinosa D, Hermida E, Larque AB, Esforzado N, Torregrosa JV, Cucchiari D, Blasco M, Rodríguez-Villar C, Beck LH, García Herrera A, Quintana LF. Antiphospholipase A2 receptor antibody-positive membranous nephropathy in the kidney donor: Lessons from a serendipitous transplantation. Am J Transplant. 2022 Jan; 22(1):299-303. PMID: 34431212
  7. Idrees N, Beck LH. Multitarget Combination Immunosuppressive Therapy for Primary Membranous Nephropathy. Am J Kidney Dis. 2021 12; 78(6):774-776. PMID: 34465505
  8. Al-Rabadi LF, Caza T, Trivin-Avillach C, Rodan AR, Andeen N, Hayashi N, Williams B, Revelo MP, Clayton F, Abraham J, Lin E, Liou W, Zou CJ, Ramkumar N, Cummins T, Wilkey DW, Kawalit I, Herzog C, Storey A, Edmondson R, Sjoberg R, Yang T, Chien J, Merchant M, Arthur J, Klein J, Larsen C, Beck LH. Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy. J Am Soc Nephrol. 2021 May 05. PMID: 33952630; PMCID: PMC8425645; DOI: 10.1681/ASN.2020101395;
  9. Lerner GB, Virmani S, Henderson JM, Francis JM, Beck LH. A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy. Kidney Int. 2021 08; 100(2):289-300.View Related Profiles. PMID: 33857571
  10. Beck LH, Berasi SP, Copley JB, Gorman D, Levy DI, Lim CN, Henderson JM, Salant DJ, Lu W. PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis. Kidney Int Rep. 2021 Jun; 6(6):1629-1633.View Related Profiles. PMID: 34169203; PMCID: PMC8207305; DOI: 10.1016/j.ekir.2021.03.892;
Showing 10 of 82 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 82 publications over 17 distinct years, with a maximum of 13 publications in 2021

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

anti-phospholipase A2 receptor autoantibodies
membranous nephropathy
Contact for Mentoring:

650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map

Beck's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department